Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Thrombocytopenia and RRM1[original query] |
---|
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research. Investigational new drugs 2012 Jun 30 (3): 1164-74. Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J |
Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy. PloS one 2012 7 (10): e48350. Zhang Ling, Gao Guanghui, Li Xuefei, Ren Shengxiang, Li Aiwu, Xu Jianfang, Zhang Jie, Zhou Caic |
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment. Leukemia & lymphoma 2017 12 58 (12): 2880-2894. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Rojas Luis, Rodríguez-Veiga Rebeca, Boluda Blanca, Sendra Luis, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
Gene-Gene Interactions of Gemcitabine Metabolizing-Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine-Induced Hematological Toxicity. Journal of clinical pharmacology 2021 5 61 (10): 1376-1385. Li Juan, Chen Bing, Xi Wen-Qi, Yang Chen, Zhang Wei-X |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: